Edition:
United States

Health News

Photo

J&J vows to overturn $4.7 billion talc verdict but experts see hurdles Jul 13 2018

NEW YORK Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri. | Video

More Headlines

China pushes for lower cancer drug prices: Xinhua

SHANGHAI China's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday.

China Jul 14 2018

U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents

A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine.

Jul 13 2018

More women may be experiencing depression during pregnancy

(Reuters Health) - Today's moms-to-be are more likely than women from their mothers' generation to become depressed while pregnant, a study suggests.

Jul 13 2018

Within opioid abuse epidemic, infectious disease epidemic emerges

NEW YORK (Reuters Health) - There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering, and Medicine workshop.

Jul 13 2018